Our multifunctional nano-nuclear-reactors combined with anti-PD-L1 nanobodies can effectively stimulate DCs maturation, polarize toward M1-type macrophage, and interference PD-1/PD-L1 pathway, thus triggering effective anti-tumor T cell immunity against primary and distant tumors, and tumor metastasis. The gene discussed is CD274; the disease is neoplasm.